Malaria Infection Induces the production of serum antibodies to a variety of malaria antigens but the prevalence of antibodies to any particular antigen Is typically much less than 100%. It has been assumed that non-responsiveness to defined antigens In malaria Immune subjects is due to HLA- 
Introduction
Protective immunity to blood stage malaria parasites is at least partly antibody dependent (1) . Inhibition of merozoite invasion into erythrocytes, opsonization and/or antibodydependent cellular cytotoxicity are believed to be the principle mechanisms of antibody-mediated immunity (2-4), and antibody responses to a number of defined erythrocyte or merozoite surface antigens correlate with acquisition of clinical immunity to malaria (5-8).
Malaria infection induces antibodies directed against both conserved and variable epitopes of merozoite antigens. The prevalence of antibodies to any particular antigen or epitope is, however, typically much less than 100% even where the epitope is highly conserved between parasite isolates and where malaria transmission rates are high enough to ensure frequent re-exposure to infection (9-15). Since immunization of MHC (H-2) congenic mice with short polypeptides derived from malaria antigens has shown that non-responsiveness (i.e. failure to produce antibody) can, in certain circumstances, be linked to H-2 genotype (16, 17) , it has been assumed that non-responsiveness to malaria antigens in humans is also the result of HLA-dependent genetic restriction of the immune response (10, 18, 19) . However, when cellular or humoral immune responses of humans immunized by natural exposure to malaria are compared with their HLA class II genotype very few associations are found between responsiveness (or non-responsiveness) and HLA gene expression (14, (20) (21) (22) (23) (24) . Since widespread non-responsiveness to defined malaria antigens could pose difficulties for the implementation of subunit vaccines, it is important that alternative explanations for individual non-responsiveness should be explored.
Most antibody prevalence data has been collected by cross-sectional analysis of a population at a single point in time. Malaria transmission is seasonal in many endemic areas and it is possible that antibody levels fluctuate over time such that individuals appear to be non-responders on some occasions and responders on other occasions. To obtain reliable estimates of antibody prevalence it is necessary to conduct longitudinal studies, collecting serum from the same individuals over a period of months or years. Few such studies have been reported.
It is clear that some regions of any given protein are more potent activators of B cells than are other regions, giving rise to immunodominant epitopes. For example, the repetitive amino acid sequences which are common in malaria proteins tend to be immunodominant (25) . However, even epitopes which are immunodominant at a population level are not universally recognized (11, 26, 27) , so immunodominance (or lack thereof) is not, in itself, a sufficient explanation for selectivity of antibody responses.
In this study we have investigated the effect, on the antibody response to conserved or semi-conserved sequences of two Plasmodium falciparum merozoite surface proteins (PfMSPI and PfMSP2) and a sexual-stage-specific antigen (Pfs260/ 230), of three potential causes of apparent non-responsiveness to malaria antigens: (i) poor immunogenicity of malaria antigens; (ii) temporal variations in antibody levels; and (ni) host genotype. The inherent immunogenicity of the antigens has been assessed by looking for specific antibody in the serum of individuals recovering from a primary malaria infection. In longitudinal serological studies, we have found that whereas antibody responses vary seasonally in children, antibody levels remain stable in clinically immune adults. Antigen recognition is selective, with some individuals consistently recognizing specific regions of some antigens whilst failing to recognize adjacent epitopes from the same protein.
To determine whether selective recognition of malaria antigens is primarily due to host genetic factors or to external 'environmental' factors, we have looked for associations between HLA class II genotype and antibody responses in malaria immune donors and have compared antibody responses in identical and non-identical twins. Recognition of these malaria antigens does not appear to be genetically regulated. We therefore propose an alternative explanation for selective antibody responses in malaria immune individuals-clonal imprinting or original antigenic sin.
(i) HLA class II study. Blood samples were obtained from a group of 283 malaria-exposed individuals (for details see 22) . HLA typing for DRB, DQA and DOB was performed by Southern blot analysis of Taq 1-cleaved DNA from peripheral blood leucocytes as described previously (22) .
(ii) Twin study. Serum samples were obtained from 36 pairs of same-sex adult twins. As the twins were raised together and were still living in the same, or nearby, villages it is likely that their past histories of malaria infection are very similar.
Fifteen pairs were shown to be monozygous by DNA probing with five separate minisatellite probes (29) .
(iii) Longitudinal studies. In the first longitudinal study 20 children were followed over a period of 4 years. All the children were under the age of 10 years at the end of the study. The second study was of 22 adults (all >16 years at the beginning of the study) followed over three transmission seasons. Serum samples were collected twice yearly-at the end of the dry season (when malaria transmission is minimal) and at the end of the wet season.
Controls. Control sera were collected from 12 European (malaria unexposed) adults and 12 European children (aged 3-8 years).
Antigens
All the antigens (Fig. 1) were recombinant proteins, fused to glutathione S transferase (GST) or maltose binding protein
Methods

Subjects
Convalesecent patients. Serum samples were obtained from six patients convalescing from primary malaria infections at the Department of Infectious Diseases and Tropical Medicine, Northwick Park Hospital. Samples were obtained 14-21 days after successful chemotherapy and were stored at -20°C.
Malaria immune/semi-immune donors. All subjects lived in rural areas of The Gambia, West Africa, where malaria transmission is seasonally endemic with the majority of new infections occurring during and after the annual rainy season (July-October) (28) . The level of malaria transmission is such that individuals are exposed to between one and five infective mosquito bites per year (28 (34) and was a gift of Dr P. Berghaus (NIMR, London, UK). EGF-1 and EGF-2 represent the MAD20 sequences of the first and second EGF-like motifs respectively, and were a gift from Dr J. Chappel (NIMR, London) (35) . Finally, MAD33 represents the MAD20 sequence of the 33 kDa dimorphic fragment (Egan et al., in preparation) All the PfMSPI antigens were GST fusion proteins.
PfMSP2. Four polypeptides, derived from a second dimorphic merozoite surface protein PfMSP2 (36) and fused to GST, were a kind gift of Dr Jana McBride (University of Edinburgh). A2 represents the N-terminal group-specific sequence of the A (3D7-like) serogroup of PfMSP2 together with the highly polymorphic tetrapeptide R1 repeat region from the Thai isolate T9/96. A3 represents the C-terminal group-specific and R2 repeat region of serogroup A. B2 and B3 represent the equivalent regions of MSP2 serogroup B (FCQ27-like). All four MSP2 antigens thus contain both semi-conserved (groupspecific) sequences and repetitive sequences which show varying degrees of polymorphism.
Pfs260/230. The r260 construct (31) represents the glutamic acid-rich tetrapeptide repeat region of the gametocyte/ gamete surface antigen Pfs260/230 (37) fused to MBP and was kindly provided by Dr Kim Williamson, Loyola University, Chicago. The repeats [predominantly (EEVG)n, but with degenerate EEEG and EGVG sequences] share sequence homology with other glutamic acid-rich malaria proteins and appear to be immunodominant in natural human infections (31) . Antibodies to the mature, native Pfs230 protein (n230) were determined by immunoprecipitation as described previously (14). Pfs260 is post-translationally processed to produce Pfs230; n230 does not contain the repeat sequences, which are deleted during the processing event.
Fusion protein controls. For all immunoassays, a control GST or MBP peptide, purified from E. coli transformed with vectors lacking an insert, was used to determine the response to the fusion protein alone.
ELISA
Microtitre plates (lmmulon-4; Dynatech, Billingshurst, UK) were coated at 4°C with 100 nJ/well of antigen at 0.5 \ig/m\ in 0.1 M carbonate (NajjCOyNaHCCy buffer (pH 9.6), blocked at room temperature with 200 nJ/well of blocking buffer (1% w/v milk powder in PBS/0.05% Tween 20) and washed three times in PBS/Tween 20. Sera were diluted 1:1000 in blocking buffer. This dilution was chosen after titration of a number of high, medium and low titre sera over a range of dilutions (1:20 to 1:40,000). In all cases, the 1:1000 dilution fell on the linear portion of the titration curve and gave maximal differentiation between exposed and non-exposed (European control) sera. Then, 100 (il of diluted serum was added to duplicate wells and incubated at 4°C overnight. Plates were washed and incubated with an optimal concentration of horseradish peroxidase-conjugated rabbit anti-human IgG antibody (Dako, High Wycombe, UK) for 3 h at room temperature. Plates were developed with H2O2 as substrate and ophenylenediamine (OPD; Sigma, Poole, UK) as chromagen and the reaction was stopped after 10 min with 20 nl/well 2 M H2SO4. The OD was measured at a wavelength of 492 nm.
To minimize interassay variation, sera from each pair of twins were tested in parallel on the same microtitre plate. For the longitudinal studies, consecutive samples from the same donor were all tested on a single plate.
Data analysis
The reactivity of the sera with malaria antigens was calculated by subtracting the OD value for the GST or MBP control from the value obtained for the fusion proteins, to obtain specific OD values. Positive sera were defined as those giving a specific OD above the normal range (mean + 2 SD) for 24 control European sera.
The association between HLA class II genotype and antibody response was tested as described previously (22) . Briefly, HLA genotype was defined by the DRB-DQA-DQB haplotype and only those haplotypes which were present in at least 10/283 people were included in the analysis. Individuals were classified as either responders or non-responders to each antigen and the probability of an immune response in individuals of any particular haplotype was estimated by multiple logistic regression allowing for the potential confounding effects of age and sex. To allow for linkage of HLA genotype and malaria exposure within members of a single family group, the data were stratified by household and analysed by conditional logistic regression.
Differences between monozygous (mz) and dizygous (dz) twins were assessed in two ways. Firstly, the proportion of discordant pairs (i.e. where one twin was seronegative and the other seropositive for any particular antigen) in each group (mz versus dz) was compared by Fisher's exact test. Secondly, the absolute difference in OD values for each twin pair (for each antigen) was calculated and the significance of the median difference between mz and dz pairs was assessed using a non-parametric Mann-Whitney test.
Results
Immunogenicity of merozoite and gametocyte surface proteins
To determine the significance of apparent non-recognition of malaria antigens by serum antibodies from malaria exposed individuals it is important to assess the relative immunogenicity of the antigens. It is not necessarily appropriate to assess the immunogenicity of a particular antigen on the basis of the proportion of responders in an immune population since even poorty immunogenic antigens may be recognized after long- term exposure. Alternatively, down-regulation of responses following frequent re-infection may underestimate the initial immunogenicity of the antigen. An alternative method for assessing the natural immunogenicity of these antigens is to examine convalescent serum samples from people who are known to have had only one or two malaria infections. We have examined convalescent sera from six such individuals (Table 1) .
MSP2 is highly immunogenic, with all six convalescent sera recognizing either the serogroup A or serogroup B proteins. Five sera recognized the highly conserved double EGF motif construct (MSPI 19 ) whilst the individual EGF motifs and the dimorphic MAD33 protein were each recognized by three sera. None of the sera from non-immune malaria patients recognized the Pfs260/230 construct, suggesting either that the sequence is poorly immunogenic or (more likely) that their infections had been cleared (by drug therapy) before significant differentiation of the asexual parasites into sexual stages. Antibodies to Pfs260/230 have previously been reported in individuals recovering from primary malaria attacks (38, 39) , indicating that the protein is highly immunogenic.
Thus, poor immunogenicity is an unlikely explanation for non-responsiveness to these particular proteins in malariaimmune individuals.
Are antibody levels, within one individual, stable over time?
To confirm that non-responsiveness to malaria antigens is a real phenomenon, it is important to determine whether responder or non-responder status is a consistent phenotype within an individual. To do this we collected multiple serum samples from children and adults, at intervals of ~6 months (i.e. during both high and low malaria transmission seasons).
In children there was clear evidence of seasonal variation in antibody responses with oscillation between seropositivity and seronegativity ( Table 2 ) and boosting of the antibody response during the malaria transmission season (Fig. 2) . It is possible to make a shrewd guess as to the MSP2 genotype of the infecting parasites, based on the rise or fall of antibodies to MSP2 serogroup A or B proteins. For example, donor E07008 shows an antibody response to serogroup A whilst E24009 shows a response to serogroup B in 1990 and to A and B in 1991 (Fig. 2) . It is also clear that some antigens are more frequently recognized than others. Surprisingly, the dimorphic antigens (MAD33, MSP2-A3 and MSP2-B3) appear to be more frequently recognized than the conserved antigens (MSP1 19 , r260, EGF-1 and EGF-2) but this may simply reflect the fact that they are somewhat larger and presumably express a more diverse array of epitopes.
In contrast to the variable responses seen in children, adult responses were much less variable over time (Fig. 3 and Table 3 ). Individuals tend to be either consistently seropositive or consistently seronegative for specific antigens. This agrees with our previous data showing that antibody responses to the native Pfs260/230 are extremely stable over time (14) . What is evident in the adults, however, is some kind of epitope selection. Nine of the adult donors possess antibodies against native Pfs230 but only four donors made antibodies to the tetrapeptide repeat sequences in the 260 kDa precursor protein. Donor 13 (Fig. 3a) is consistently antibody positive for MSP2-A3, B2 and B3 but negative for MSP2-A2. Donor 45 (Table 3 and Fig. 3b ) recognizes MAD33 and MSP2 but fails to recognize the MSP1 19 proteins. Some donors (e.g. 79) make strong antibody responses to all the antigens tested and all donors (with the exception of donor 109) make consistent responses to at least one of the antigens tested.
Is the pattern of antibody recognition of MSP1 and MSP2 genetically determined?
To determine whether persistent non-responder status in adults is genetically determined, the effects of HLA class II genes and non-HLA genes on antibody responses were examined. Table 4 summarizes the results of the statistical analysis of the relationship between HLA class II haplotype and antibody responses to MSP1 and MSP2. No significant associations were seen between any of the antigens tested and any HLA class II antigen. The relationship between HLA class II and antibodies to r260 was analysed, but few individuals were tested for each haplotype (data not shown) and although no association was found (x 2 = 3.04, P = 0.55), the group sizes were too small for any definitive conclusions to be drawn.
Sera from 15 pairs of adult mz twins and 21 pairs of adult dz twins were tested for recognition of MSP1 19 and MSP2 (Table 5) . Overall, the level of concordance is high (36 pairs tested against five antigens = 180 comparisons, of which 142 = 79% were concordant), this presumably reflects the similarity of past malaria exposure within the pairs. However, some pairs are clearly discordant, with one twin showing a strong antibody response to a particular antigen and the other twin being seronegative. If these differences were the result mainly of genetic differences between the twins, one would expect that more dz than mz pairs would be discordant, but this is not the case. There was no significant difference between mz and dz twins in either the proportion of discordant pairs (Fisher's exact test, P > 0.90 for all antigens) or the median within-pair difference in OD values (Mann-Whitney; P > 0.07 for all antigens). In other words, mz pairs are no more alike than are dz twins and genetically identical mz twins can have very different antibody responses.
Sufficient serum was available from eight pairs of twins (three mz and five dz) for testing responses to r260; all eight pairs gave concordant responses (i.e. both negative or both positive), although we have previously demonstrated discordant responses to native Pfs260/230 within monozygous twin pairs (14).
Discussion
Limited antibody recognition of malaria merozoite antigens is a potential problem for vaccine development, particularly if non-responsiveness is genetically determined, as a proportion of any given population may be unable to respond to vaccination. Although non-responsiveness to malaria antigens has been widely reported (9,10,14,18,20) there has been little attempt to determine the cause. In this study we have investigated the role of three factors, i.e. immunogenicity of the antigens, temporal fluctuations in antibody titre and host genotype, in the response to defined epitopes of two merozoite surface antigens, MSP1 and MSP2 and a gametocyte surface antigen Pfs260/230. To overcome the confounding effects of antigenic polymorphism and heterogeneity of malaria exposure, we have deliberately selected antigens representing semi-conserved or conserved protein sequences which are commonly expressed by parasites circulating in the study area (40) . We also selected antigens which we believed would be highly immunogenic-in that >50% of immune adults have antibodies to them (15,31,32) (A. Egan et al., unpublished). The immunogenicity of the antigens used is confirmed by the presence of high titre antibody responses during the convalescent phase of primary malaria infections (this paper and 38,39).
Previous studies in human populations have not shown any significant association between naturally acquired antibody responses to defined malaria antigens and HLA class II genotype (14, [20] [21] [22] [23] [24] . In this study, we present data on the relationship between HLA class II and responses to MSP1, MSP2 and r260 antigens in almost 300 malaria-immune individuals and found no significant associations between the two variables. Similarly, no such associations were observed in a separate group of 355 individuals (data not shown). However, demonstration of HLA associated non-responsiveness in outbred human populations is hindered by the extreme genetic diversity of even quite small communities (41) (42) (43) and by the heterogeneity of antigenic challenge, particularly for polymorphic micro-organisms such as malaria parasites (40) . In this study we have overcome this problem by comparing the immune responses of twins who have a shared genetic background and similar malaria exposure histories.
A study of 34 twin pairs by Sj6berg et al. (44) suggested that antibody responses to repetitive epitopes of the erythrocyte membrane antigen R155/RESA might be genetically determined. However, it is worth noting that this is the only malaria antigen for which an association between MHC and antibody production has been demonstrated (22) ; responses to Pf155/ RESA are thus not typical of responses to other malaria antigens. In contrast, in the present study, comparison of antibody responses in identical and non-identical twins indicates that genetic background is not a major factor in determining antibody responsiveness to MSP1, MSP2 and r260. This is in agreement with our previous observations for antibody responses of twins to native Pfs260/230 (14) and with data from a much larger study (267 pairs) of African twins (A. Jepson er a/., personal communication). We have shown that, despite life long exposure to malaria, monozygous twin pairs can have clearly discordant antibody responses to the same antigen and we therefore conclude that genetic factors do not play a major role in determining serological responsiveness or non-responsiveness to these particular malaria antigens. We therefore turned to an examination of temporal (environmental) factors which may influence the response. We compared patterns of antibody responsiveness over time in a group of 20 partially immune children who were still susceptible to clinical malaria infection (and who experience high levels of parasitaemia when infected) with the pattern of responses in clinically immune adults who experienced only asymptomatic, low level, infections. The pattern of responses in children was not unexpected-there was clear evidence of seasonal variation in antibody levels with titres rising at the Each symbol represents a separate serum sample Samples were collected at 6 month intervals. -= antibody negative, + = antibody positive, + = strongly antibody positive (definitions as for Table 2) This data has, in part, been published previously (31). 1  w15  w17  w18  3  4  4  7  7  w8  w8  9  w10  W11  w11  w11  w13  w13  w13  w13   specificity   DQ   w5  w6  w2  w4  w4  w8  w2  w2  w2  w7  w7  w2  w5  w7  w7  w7  w6  w6  w6 Proportion of individuals expressing each haptotype who were seropositive for each antigen, x 2 is conditional logistic regression statistic for overall association between HLA type and immune response. a n = 1 less for MSP1 proteins; b n = 2 less for MSP1 proteins; c n = 3 less for MSP1 proteins. d Results for unconditional (standard) logistic regression since conditional model did not converge for any combination of haplotypes. MSP2-A2  MSP2-A3  MSP2-B2  MSP2-B3   MZ1  MZ2  MZ3  MZ4  MZ5  MZ6  MZ7  MZ8  MZ9  MZ10  MZ11  MZ12  MZ13  MZ14  MZ15   DZ1  DZ2  DZ3  DZ4  DZ5  DZ6  DZ7  DZ8  DZ9  DZ10  DZ11  DZ12  DZ13  DZ14  DZ15  DZ16  DZ17  DZ18  DZ19  DZ20  DZ21 Cut off values for positive responses (mean + 2SD of control sera) The first figure in each column represents the OD value for one twin, the second figure is the OD value for the other twin in the pair Discordant results (one above and one below cut off) are underlined.
"Monozygous twin first b Fisher's exact text. c Mann-Whitney Otest end of the malaria transmission season. However, even in children it was evident that responses to some antigens were being induced more readily than others. For example, epitopes within MSPI19 would have been present during every infection but a response to this protein was seen in some children but not in others. Antibody levels were remarkably stable in adults, with individuals remaining consistently seropositive or consistently seronegative with respect to individual antigens. Individual donors were clearly able to recognize different antigens in a selective manner, recognizing some regions of an antigen but failing to recognize adjacent regions of the same protein.
Few immuno-epidemiological studies have examined antibody responses to malaria antigens over a period of months or years in the same person, but in a 2 year study in Liberia, Bjorkman era/. (45) found that antibodies to Pf 155/RESA were consistent on consecutive surveys and they were able to divide their cohort into responders or non-responders. These workers ascribed the stability of responses to genetic restriction but provided no supporting evidence. Interestingly, in a longitudinal study conducted in Madagascar (where an epidemic outbreak of P. falciparum occurred after 20 years without malaria transmission), clear seasonal variation in the titre of anti-Pf155/RESA antibodies was seen in both children and adults (46) . This supports our conclusion that antibody levels stabilize in malaria-immune individuals but fluctuate according to recent malaria exposure in non-immunes or semi-immunes. The age at which antibody levels begin to stabilize may depend on the intensity of malaria transmission and on the antigen in question. In an area of perennial, holoendemic malaria transmission, Bjorkman etal. (47) found that seropositivity to Pf155/RESA was consistent from season to season in children aged 3-5 years. We have previously found stable antibody responses to Pfs260/230 in children as young as 3-5 years old (14) and in this study responses of some children to MSP2-B3 were very consistent. But, on the whole, responses to merozoite surface antigens, and to the repeat region of Pfs260/230, do not seem to stabilize until later in life Since recognition of these malaria epitopes does not appear to be genetically determined and since antibody repertoires appear to become fixed in clinically immune adults, we have considered the possibility that the selective recognition of these antigens may be the result of clonal imprinting (original antigenic sin).
The term 'original antigenic sin' was first used to explain the observation that adult humans vaccinated against influenza produced antibodies with higher affinity for strains to which they had been exposed in childhood than for the vaccine strain (48, 49) and has recently been invoked as a possible explanation for the high frequency of human T cells specific for epitopes which are shared between different micro-organisms (50) . The molecular basis of original antigenic sin was subsequently shown to be the presence of cross-reactive epitopes within the polymorphic viral haemagglutinin (51, 52) . On primary infection, specific clones of naive T and B cells proliferate and transform into memory cells. Memory B cells have higher avidity for antigen than naive B cells as they express more surface Ig (slg) and somatic mutation of the Ig genes results in expression of slg of higher affinity (53) . On secondary infection, memory B cells successfully compete with naive B cells for antigens which cross-react with the original infection and antibody of the original specificity is produced. Epitopes which were not present in the original infection, or which induced memory cells of lower affinity, are effectively ignored Since relative affinity of slg for antigen is crucial to this process, it follows that the effect can be overcome by high doses of antigen (52) .
There are many features of malaria infection which make clonal imprinting a likely explanation for the selective antibody responses seen in malaria-immune individuals. Firstly, malaria antigens are composed of both conserved (or semi-conserved) and polymorphic epitopes (54) , so cross-reactive immune responses would be expected. Antigens which are not in themselves noticeably polymorphic [e.g. R155/RESA or Pfs260/230 (55-57)] share repetitive, glutamic acid-rich epitopes giving rise to an extensive family of cross-reacting antigens (58) . Secondly, people are infected many times by malaria and polymorphism within malaria parasite populations is extensive enough (59) that it is highly likely that successive infections would be of differing genotypes. Finally, in clinically immune individuals, blood stage infections are of very low density so that competition for antigen may occur between B cells of differing affinity. In this case, high-affinity responses would be boosted and low-affinity responses would eventually be lost. This may explain why the prevalence of antibodies to certain antigens appears to be higher in individuals recovering from a primary malaria infection than in immune or semiimmune individuals (60) .
As yet, there is no direct evidence that clonal imprinting occurs to malaria antigens, but the data presented here are consistent with such an explanation. Confirmation requires longitudinal studies where the development of antibody responses can be monitored in individuals whose infection history is carefully documented in terms of parasite genotype. We have recently initiated such a study in West Africa to confirm or refute the clonal imprinting hypothesis.
If the low prevalence of antibodies to certain antigens is due to clonal imprinting, injudicious vaccine design will cause serious problems, particularly in endemic populations where priming of anti-malarial immune responses may occur prior to vaccination. However, antibody responses to a synthetic vaccine antigen may be more widespread than responses to the same antigen following natural infection, as the presentation of an antigen in the absence of the epitope to which the immune system has become imprinted, would allow imprinting to be circumvented.
Finally, the maintenance (in adults) of high levels of antimalarial antibody from year to year indicates that malarial antigens induce efficient memory responses-this bodes well for the induction of long term immunity following vaccination. 
